Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5385205

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of JAK3 (unknown origin)
5
Total Activities
5
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Tyrosine-protein kinase JAK3 (CHEMBL2148)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Exploration of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Bispecific Inhibitors Based on the Moiety of Fedratinib for Treatment of Both Hematologic Malignancies and Solid Cancers.
Qiu Q, Chi F, Zhou D, Xie Z, Liu Y, Wu H, Yin Z, Shi W, Qian H.
J Med Chem (2023) 66 : 5753 -5773
PubMed 37057760 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 5 6.99 8.70

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL1789941 RUXOLITINIB 4.0 1 8.70
CHEMBL221959 TOFACITINIB 4.0 1 7.47
CHEMBL1287853 FEDRATINIB 4.0 1 6.51
CHEMBL5433552 1 6.23
CHEMBL5395502 1 6.02

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL1789941 RUXOLITINIB IC50 = 2.0 nM 8.70
CHEMBL221959 TOFACITINIB IC50 = 34.0 nM 7.47
CHEMBL1287853 FEDRATINIB IC50 = 311.5 nM 6.51
CHEMBL5433552 IC50 = 594.8 nM 6.23
CHEMBL5395502 IC50 = 954.1 nM 6.02